Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Predictors of kidney dysfunction in heart transplant recipients

P Przybyłowski, J Małyszko, J Małyszko

Ann Transplant 2009; 14(1): 32-32 :: ID: 880314


Background: Cardiovascular disease and kidney disease seem to be lethally synergistic and both approach the level of epidemic. Patients with cardiovascular disease have often impaired kidney function, while on the other hand cardiovascular disease is the single best predictor of mortality in patients with chronic kidney disease. The risk in a patient with moderate impaired renal function is comparable in magnitude with that of a patient with diabetes mellitus. The aim of the study was to assess the risk factors for kidney dysfunction in a 162 consecutive heart transplant recipients (129 males, 22 females). Stages of chronic kidney disease were defi ned according to K/DOQI guidelines using estimated GFR.
Results: Mean serum creatinine in this population was 1.70±1.08 mg/dl (ranges from 0.54-9.34 mg/dl); mean age was 54±14 years; mean time after transplantation was 106±52 months (ranges 10-210 months). Mean GFR was 62.92±31.04 ml/min (Cockcroft-Gault formula), 55.38±26.74 ml/min (MDRD) and 62.62±35.61 ml/min (creatinine clearance). Estimated GFR, creatinine clearance, serum creatinine correlated in univariate analysis with haemoglobin, RBC count, age, time after transplantation, ejection fraction, NT-proBNP, use of calcineurine inhibitors. In multiple regression analysis predictors of kidney function (GFR) were age (beta value -0.47, p<0.001), time after transplantation (beta value -0.22, p=0.03) and haemoglobin (beta value 0.31, p-0.03) explaining the 51% of variation of GFR in this group. When GFR was substituted by creatinine clearance the results were the same. Conclusions: In heart transplant recipients kidney function is predominantly dependent upon age, time after transplantation (both non-modifi able causes) and anaemia (which could be modified).

Keywords: Heart Transplantation, Immunosuppression

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358